(Q34535902)

2 August 2017

1 reference

title

The immunology of psoriasis and biologic immunotherapy (English)

1 reference

2 August 2017

1 reference

1 reference

Stephanie L Mehlis

1

1 reference

2 August 2017

Kenneth B Gordon

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Journal of the American Academy of Dermatology

2 August 2017

published in

1 reference

2 August 2017

volume

49

1 reference

2 August 2017

issue

2 Suppl

1 reference

2 August 2017

page(s)

S44-50

1 reference

Current consensus and update on psoriasis therapy: a perspective from the U.S.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Characterization of Mononuclear Cell Infiltrates in Psoriatic Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Pulling the trigger on psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Histological and immunocytochemical studies of human psoriatic lesions transplanted onto SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Repeated subcutaneous injection of staphylococcal enterotoxin B-stimulated lymphocytes retains epidermal thickness of psoriatic skin-graft onto severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

DAB486IL-2 (IL-2 Toxin) Selectively Inactivates High-Affinity IL-2 Receptor-Bearing Human Peripheral Blood Mononuclear Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Lymphocyte activation in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Complexity in the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

T lymphocyte activation--an inside overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Intercellular transfer of antigen-presenting cell determinants onto T cells: molecular mechanisms and biological significance.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Interaction of T cells with APCs: the serial encounter model

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

ELAM-1 is an adhesion molecule for skin-homing T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Inflammatory skin diseases, T cells, and immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Cytokines in psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Psoriasiform eruption triggered by recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and exacerbated by granulocyte colony stimulating factor (rG-CSF) in a patient with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Biologic therapy for psoriasis: the new therapeutic frontier

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

T cells involved in psoriasis vulgaris belong to the Th1 subset

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Immune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation. No 14874 and No 14393 Zenapax Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Different growth properties in response to epidermal growth factor and interleukin-6 of primary keratinocytes derived from normal and psoriatic lesional skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

OKT3 first-dose reaction: association with T cell subsets and cytokine release

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Expression of interleukin-12 is increased in psoriatic skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Dermal injection of immunocytes induces psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901134-4

7 January 2021

10.1016/S0190-9622(03)01134-4

Identifiers

DOI

1 reference

2 August 2017

1 reference